Related Articles

Vaccines and returning to a more familiar world
- Our Blog
Jan 05, 2021

Anwiti Bahuguna, Ph.D., Senior Portfolio Manager, Head of Multi-Asset Strategy

2021 economic outlook: Build longer term forecasts around successful vaccine distribution and expect stronger economic growth in the second half of 2021.
Relax over the holidays with our top book picks
- Our Blog
Dec 22, 2020

Columbia Threadneedle Investments

After a demanding year, it’s time to take a well-deserved break at the holidays. We asked our colleagues to share a book (or podcast) that they enjoyed in 2020.
Chart: The race toward a COVID-19 vaccine
- Chart on the Go
Oct 02, 2020

Kosta Kleyman, PharmD, Analyst, Equity Research

Three technologies present our best chances for developing a vaccine. But how effective will they be?
The state of the U.S. consumer
- Our Blog
Sep 29, 2020

Kris Moreton, CFA, Senior Vice President, Fixed-Income Client Portfolio Manager

Households are proving to be financially resilient during the COVID-19 pandemic, but does investing in consumer debt still make sense?
Chart: Vaccine developments, milestones and unknowns
- Chart on the Go
Aug 18, 2020

Lawrence W. Lin, CFA, Senior Analyst and Senior Portfolio Manager, Equity Research

Kosta Kleyman, PharmD, Analyst, Equity Research

Our latest chart maps out the most important vaccine developments as the world races to conquer COVID-19.

 Contact Us

Mutual Funds Marketing Support and Literature Requests

Mon - Fri: 8am - 6pm ET

Financial Institutions: 800.718.9009
Broker/Dealers: 800.215.5005
Registered Investment Advisors: 866.444.5435
Independent Advisors: 800.446.4008
Dealer Services Fri: 8am - 7pm ET: 800.322.2847

Service inquiries: Email us email
Product inquiries: Email us email
Sales/Prospecting questions: Email us email

Shareholder Account Services

Mon - Fri: 8am – 7pm ET

Shareholder Services: 800.345.6611
Transaction Department: 800.422.3737

Privacy and Security Terms and Conditions Corporate Entities Disclosures Glossary^†

© 2016-2021 Columbia Management Investment Advisers, LLC. All rights reserved.

Use of products, materials and services available through Columbia Threadneedle Investments may be subject to approval by your home office.

^† By clicking the Glossary link above, you will be leaving columbiathreadneedle.com/us. View our Terms and Conditions for our hyperlinking disclosure.

With respect to mutual funds, ETFs and Tri-Continental Corporation, investors should consider the investment objectives, risks, charges and expenses of a fund carefully before investing. To learn more about this and other important information about each fund, download a free prospectus. The prospectus should be read carefully before investing.
Investors should consider the investment objectives, risks, charges, and expenses of Columbia Seligman Premium Technology Growth Fund carefully before investing. To obtain the Fund's most recent periodic reports and other regulatory filings, contact your financial advisor or download reports here. These reports and other filings can also be found on the Securities and Exchange Commission's EDGAR Database. You should read these reports and other filings carefully before investing.

The views expressed are as of the date given, may change as market or other conditions change and may differ from views expressed by other Columbia Management Investment Advisers, LLC (CMIA) associates or affiliates. Actual investments or investment decisions made by CMIA and its affiliates, whether for its own account or on behalf of clients, may not necessarily reflect the views expressed. This information is not intended to provide investment advice and does not take into consideration individual investor circumstances. Investment decisions should always be made based on an investor's specific financial needs, objectives, goals, time horizon and risk tolerance. Asset classes described may not be appropriate for all investors. Past performance does not guarantee future results, and no forecast should be considered a guarantee either. Since economic and market conditions change frequently, there can be no assurance that the trends described here will continue or that any forecasts are accurate.

Columbia Funds and Columbia Acorn Funds are distributed by Columbia Management Investment Distributors, Inc., member FINRA. Columbia Funds are managed by Columbia Management Investment Advisers, LLC and Columbia Acorn Funds are managed by Columbia Wanger Asset Management, LLC, a subsidiary of Columbia Management Investment Advisers, LLC. ETFs are distributed by ALPS Distributors, Inc., member FINRA, an unaffiliated entity.

Columbia Threadneedle Investments (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies.